GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Transgene Biotek Ltd (BOM:526139) » Definitions » Price-to-Tangible-Book

Transgene Biotek (BOM:526139) Price-to-Tangible-Book : 9.26 (As of May. 28, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Transgene Biotek Price-to-Tangible-Book?

As of today (2025-05-28), Transgene Biotek's share price is ₹4.26. Transgene Biotek's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was ₹0.46. Hence, Transgene Biotek's Price to Tangible Book Ratio of today is 9.26.

The historical rank and industry rank for Transgene Biotek's Price-to-Tangible-Book or its related term are showing as below:

BOM:526139' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.75   Med: 7.28   Max: 32.25
Current: 9.26

During the past 13 years, Transgene Biotek's highest Price to Tangible Book Ratio was 32.25. The lowest was 2.75. And the median was 7.28.

BOM:526139's Price-to-Tangible-Book is ranked worse than
84% of 1194 companies
in the Biotechnology industry
Industry Median: 2.715 vs BOM:526139: 9.26

A closely related ratio is called PB Ratio. As of today, Transgene Biotek's share price is ₹4.26. Transgene Biotek's Book Value per Sharefor the quarter that ended in Mar. 2025 was ₹1.32. Hence, Transgene Biotek's P/B Ratio of today is 3.22.


Transgene Biotek Price-to-Tangible-Book Historical Data

The historical data trend for Transgene Biotek's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Transgene Biotek Price-to-Tangible-Book Chart

Transgene Biotek Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.25 4.59 3.92 14.83 7.28

Transgene Biotek Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.83 - 13.82 - 7.28

Competitive Comparison of Transgene Biotek's Price-to-Tangible-Book

For the Biotechnology subindustry, Transgene Biotek's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Transgene Biotek's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Transgene Biotek's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Transgene Biotek's Price-to-Tangible-Book falls into.


;
;

Transgene Biotek Price-to-Tangible-Book Calculation

Transgene Biotek's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2025 )
=4.26/0.46
=9.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Transgene Biotek Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Transgene Biotek's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Transgene Biotek Business Description

Traded in Other Exchanges
N/A
Address
Anrich Industrial Area, Plot No. 69 and 70, IDA Bollaram, Sangareddy District, Medak, TG, IND, 502325
Transgene Biotek Ltd is an India-based research and development company. It is engaged in the research and development of molecules and technologies for the production of active pharmaceutical ingredients and other pharmaceutical products. The company is operating only in one segment of Bulk Drugs. Its product portfolio includes TrabiDHA, Tracolimus, and Orlistat. It generates revenue from the sale of goods and services.

Transgene Biotek Headlines

No Headlines